Health Care & Life Sciences » Biotechnology | Theratechnologies Inc.

Theratechnologies Inc.

Theratechnologies Inc.
Stock Exchange Other OTC
EPS
 $0.05
Market Cap
 $399.46 M
Shares Outstanding
 76.66 M
Public Float
 -
Theratechnologies Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 76.66 M
Public Float
 -
Theratechnologies Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
 CAD0.06
Market Cap
 CAD518.16 M
Shares Outstanding
 65.93 M
Public Float
 64.76 M

Profile

Address
2015 Peel Street
Montréal Québec H3A 1T8
Canada
Employees -
Website http://www.theratech.com
Updated 07/08/2019
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). It offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada.

Financials

View All
Created with Highcharts 5.0.14Theratechnologies Inc.Net Income. Fiscal year is December-November. All values CAD Thousands.4 0554 05510 54110 5411 5711 57141041018 45018 4506 0136 01320132014201520162017201805k10k15k20k
Created with Highcharts 5.0.14Theratechnologies Inc.Sales/Revenue. Fiscal year is December-November. All values CAD Thousands.7 5537 5536 7326 73230 05530 05537 07237 07242 86442 86458 55358 553201320142015201620172018010k20k30k40k50k60k70k

Luc Tanguay
President, Chief Executive Officer & Director
Dawn Svoronos
Chairman
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.